ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
Effective June 1st, CordenPharma will operate two business groups, APIs and Drug Products. This occurs in response to strong growth and reflects the distinct nature of these businesses. The two businesses will continue to report to the President of CordenPharma, Dr. Wolfgang Niedermaier.
Dr. Karsten Benzing, currently Executive Principal at ICIG S.E., will assume the position of Chief Operating Officer of the CordenPharma Drug Product business, in addition to his current role. In his new role he will oversee CordenPharma Caponago, CordenPharma Latina and CordenPharma Plankstadt.
Dr. Christian Ewers, currently General Manager of CordenPharma Switzerland, will assume the position of Chief Operating Officer of the CordenPharma API business, in addition to his current role. In his new role he will assume responsibility for both CordenPharma’s proprietary APIs as well as custom manufacturing businesses. He will oversee CordenPharma Colorado, CordenPharma Switzerland, Farchemia and CordenPharma France.
View the full press release here.